shutterstock 246073315

Carlsquare advises c-LEcta on financing round by Capricorn Venture Partners and bm|t

29 Aug 2018

c-LEcta, a world-leading biotechnology company focused on enzyme engineering and applications in regulated markets like food and pharma, has closed a financing round with Capricorn Venture Partners and the German investment company bm|t. The capital increase, advised by Carlsquare, provides the company with growth capital as well as valuable access to an international network.

c-LEcta already has a diversified shareholder structure. In addition to the founder, Dr. Marc Struhalla, private industrial investors and German institutionals, the company has now expanded its circle of shareholders by attracting international investors. c-LEcta has received growth capital from two new shareholders. Lead investor, Capricorn Venture Partners, is an independent, internationally oriented investment company, based in Leuven, Belgium. Capricorn invests in innovative, technology driven companies and has a multidisciplinary team of experienced investment professionals. Capricorn invested through two funds, namely the Capricorn Sustainable Chemistry Fund NV and Quest for Growth NV.

The German investment company bm|t invests in high-growth technology companies led by entrepreneurial teams. bm|t invested via the MFT Mittelstands-Fonds Thüringen GmbH [&] Co. KG. These new funds are planned to be particularly invested in the approval, launch and scale-up of 

products from the project pipeline, further development of the pipeline as well as the expansion of international sales.
c-LEcta is a fully integrated world-leading biotechnology company with focus on enzyme engineering and application in regulated markets like food and pharma. The company is located in Leipzig, Germany, and has established itself as a leading player in the realization of high-value biotech products, either in the form of in-house developments or in close cooperation with industry. The company currently employs around 60 people. c-LEcta delivers cost-efficient and sustainable production processes which open new markets and allow for better penetration of existing markets. The company is characterized by fast and efficient development of best-in-class biotech solutions and a rapid and successful market introduction and commercialization of the resulting products. This enables c-LEcta to leverage the unique potential of its core technologies. c-LEcta has a proven track record of more than 10 successfully commercialized high-value industrial biotech products.

Mr. Ludwig Goris, Investment Manager of Capricorn, commented on the investment in c-LEcta: “We see that global mega trends and challenges in human nutrition are paving the way for industrial biotech companies like c-LEcta. Since its foundation, c-LEcta has built up a remarkable track record of technology and product development and has been able to validate that through a growing customer base of leading pharma, chemical and food ingredient companies. In addition, we were impressed by the highly qualified team in Leipzig. Founder and CEO Dr. Marc Struhalla and his motivated team have created a great company that has arrived at an attractive inflection point where the current product pipeline forms the foundation for an accelerated growth curve. We are proud to lead this growth capital round and contribute to the success of c-LEcta.”

Kevin Reeder, CEO of bm|t added, “bm|t, which has a substantial life sciences portfolio, is very optimistic about its investment in c-LEcta. The company´s strong team, track record of successful development, and a highly compelling product pipeline were extremely impressive. We feel c-LEcta is well-positioned to transition to a high-value biotechnology product company.” The two new investors expand the group of shareholders, which previously included the following investors: SHS Gesellschaft für Beteiligungsmanagement mbH, High-Tech Gründerfonds Management GmbH, KfW Bankengruppe, Dr. Marc Struhalla, Warning Beteiligungs GmbH, Dr. Bader Beteiligungs GmbH, and Arthur Steinmetz Beteiligungs GmbH.

CEO Dr. Marc Struhalla commented on c-LEcta’s core technology and the capital increase: “The performance requirements for enzymes to be applied in industrial processes are in most cases very specific and vary from naturally occurring variations. Enzymes therefore need to be adapted to industrial conditions via enzyme engineering, and c-LEcta owns one of the most efficient technology platforms in this area. For enzyme optimization as well as for the development of artificial enzyme activities, we use patent-protected strategies that are inspired by nature. The industrial application of these technologies holds great market potential. The financial strength and valuable international network that we have gained through this financing round now offers us the opportunity to develop the full potential of our technology and people. With Capricorn Venture Partners and bm|t, we get two active investors on board that can contribute substantially to our international growth ambitions. Also, I am all the more pleased that our new CFO Thomas Pfaadt will support us in this endeavor. Our goal is that in the future c-LEcta´s technology will be employed in many things we encounter in everyday life.”

 

Contact:

Caspar Stauffenberg

Sebastian Fischer

Gerrit Zwarg

Team

Picture of Jessica Algner
Jessica Algner

Assistant

Telephone: +49 30 809 33 47-12

LinkedIn

@

Picture of Polina Amini
Polina Amini

Senior Associate

Telephone: +49 40 300 836-14

LinkedIn

@

Picture of Markus Augustsson
Markus Augustsson

Head of Equity Research

Telephone: +46 76 235 03 20

LinkedIn

@

Picture of Agata Barsallo
Agata Barsallo

Office Management & Accounting

Telephone: +44 20 8017 6020

@

Picture of Caroline Berglund
Caroline Berglund

Head of Equity Sales

Telephone: +46 73 382 10 82

LinkedIn

@

Picture of Anders Bo
Anders Bo

Managing Partner

Telephone: +45 4199 8252

LinkedIn

@

Picture of Ulf Boberg
Ulf Boberg

Senior Advisor Life Sciences

Telephone: +46 73 312 44 90

LinkedIn

@

Picture of Manfred Drax
Manfred Drax

Partner

Telephone: +49 89 255 49 53-15

LinkedIn

@

Picture of Germar Ebner
Germar Ebner

Associate

Telephone: +49 40 300 836-26

LinkedIn

@

Picture of Anders Elgemyr
Anders Elgemyr

Managing Partner

Telephone: +46 70 496 18 15

LinkedIn

@

Picture of Maximilian Fidel
Maximilian Fidel

Associate

Telephone: +49 89 255 49 53 24

@

Picture of Sebastian Fischer
Sebastian Fischer

Director

Telephone: +49 89 255 49 53-12

LinkedIn

@

Picture of Daniel Garlipp
Daniel Garlipp

Managing Partner

Telephone: +49 40 300 836-19

LinkedIn

@

Picture of Philip Goldhahn
Philip Goldhahn

Vice President

Telephone: +49 40 300 836-21

LinkedIn

@

Picture of Thorsten Grandt
Thorsten Grandt

Vice President

Telephone: +49 30 809 33 47-20

LinkedIn

@

Picture of Johan Heigard
Johan Heigard

Vice President

Telephone: +46 70 246 99 88

LinkedIn

@

Picture of Caroline Heintz
Caroline Heintz

Associate

Telephone: +46 707 40 68 58

@

Picture of Maurice Hinrichs
Maurice Hinrichs

Associate

Telephone: +49 40 300 836-20

LinkedIn

@

Picture of Arnold Holle
Arnold Holle

Managing Partner

Telephone: +44 20 80176020

LinkedIn

@

Picture of Lars Johansen
Lars Johansen

IT&Telecom Expert

@

Picture of Elaine Kelly
Elaine Kelly

Head of Marketing

Telephone: +49 40 300 836 18

LinkedIn

@

Picture of Anna-Lena Kickbusch
Anna-Lena Kickbusch

Office Management & Accounting

Telephone: +49 40 300 836 10

LinkedIn

@

Picture of Morten Kjærulff
Morten Kjærulff

Partner

Telephone: +45 2634 9031

LinkedIn

@

Picture of Mischa Krause
Mischa Krause

Director

Telephone: +49 40 300 836-24

LinkedIn

@

Picture of Steffen Leckert
Steffen Leckert

Managing Partner

Telephone: +49 89 255 49 53 26

LinkedIn

@

Picture of Malve Liebig
Malve Liebig

Senior Associate

Telephone: +49 89 255 49 53-18

LinkedIn

@

Picture of Erik Lundberg
Erik Lundberg

Director

Telephone: +46 73 850 35 59

LinkedIn

@

Picture of Eva Macha
Eva Macha

Office Management & PA to Michael Moritz

Telephone: +49 30 809 33 47-10

LinkedIn

@

Picture of Mandy May
Mandy May

Head of Operations

Telephone: +49 30 809 33 47 16

LinkedIn

@

Picture of Mirja Meyer
Mirja Meyer

Office Management & Accounting

Telephone: +49 40 300 836 10

@

Picture of Mark Miller
Mark Miller

Managing Partner

Telephone: +49 40 300 836-11

LinkedInXING

@

Picture of Michael Moritz
Michael Moritz

Managing Partner

Telephone: +49 30 809 33 47-13

LinkedIn

@

Picture of Bertil Nilsson
Bertil Nilsson

Senior Equity Analyst

Telephone: +46 70 434 90 03

LinkedIn

@

Picture of Flemming C. Pedersen
Flemming C. Pedersen

Managing Partner

Telephone: +45 4199 8251

LinkedIn

@

Picture of Richard Ramanius
Richard Ramanius

Associate Equity Analyst

Telephone: +46 73 539 66 99

LinkedIn

@

Picture of Anika Schaefer
Anika Schaefer

Office Management & HR

Telephone: +49 89 255 495 310

@

Picture of Alexander Schleppegrel
Alexander Schleppegrel

Associate

Telephone: +45 2621 0543

LinkedIn

@

Picture of Nico Schmidt-Weidemann
Nico Schmidt-Weidemann

Partner

Telephone: +49 89 255 49 53-17

@

Picture of Caspar Graf Stauffenberg
Caspar Graf Stauffenberg

Managing Partner

Telephone: +49 89 255 49 53-11

LinkedIn

@

Picture of Gregor Steins
Gregor Steins

Associate

Telephone: +49 40 300 836-15

LinkedIn

@

Picture of Jon Tingling
Jon Tingling

Associate

Telephone: +44 77 1347-8286

LinkedIn

@

Picture of Sybille de Vegvar
Sybille de Vegvar

Business Development & Marketing

Telephone: +44 20 8017 6017

@

Picture of Oskar Wollert
Oskar Wollert

Vice President

Telephone: +46 761 71 11 60

@

Picture of Nils Zettelmeyer
Nils Zettelmeyer

Director

Telephone: +49 30 809 33 47-25

LinkedIn

@

Picture of Andreas Zetzsche
Andreas Zetzsche

Partner

Telephone: +49 30 809 3347 33

@

Picture of Gerrit Zwarg
Gerrit Zwarg

Senior Associate

Telephone: +49 40 300 836-28

LinkedIn

@